Thomas Moumneh

Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism

Benjamin Planquette, Laurent Bertoletti, Anaïs Charles‐Nelson et al. · CHEST Journal · 2021 · 159 citations

Medicine, Pharmacology, Pharmacotherapy +14

Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial

Pierre‐Marie Roy, Andréa Penaloza, Olivier Hügli et al. · European Heart Journal · 2021 · 146 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Pulmonary embolism rule-out criteria (PERC) rule in European patients with low implicit clinical probability (PERCEPIC): a multicentre, prospective, observational study

Andréa Penaloza, Caroline Soulié, Thomas Moumneh et al. · The Lancet Haematology · 2017 · 96 citations

Medicine, Clinical Sciences, Internal Medicine +14

Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation

Grégoire Le Gal, Michael J. Kovacs, Laurent Bertoletti et al. · Annals of Internal Medicine · 2021 · 76 citations · Full text

Medicine, Hematology, Internal Medicine +16

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial

Françis Couturaud, Jeannot Schmidt, Olivier Sanchez et al. · The Lancet · 2025 · 71 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17